Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Partial Knee Replacements for Arthritis Are Safer than Total Replacement

July 8, 2014 By University of Oxford

Partial knee replacement surgery for severe osteoarthritis is safer than total knee replacement, according to an Oxford University study published in the medical journal The Lancet.

People undergoing partial knee replacement surgery, in which only the parts of the knee affected by osteoarthritis are removed, have fewer complications, are less likely to be re-admitted to hospital and less likely to die, the researchers found.

However, they are also more likely to have revision surgery – a repeat operation in which the implant has to be replaced.

Professor David Murray led the research at the Nuffield Departmental of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford. He said, “For an individual patient, the decision whether to have a partial or total [knee replacement] is based on an assessment of the relative risks and benefits. The main benefit of the partial knee is that it provides better function.”

“To put the risks in perspective, if 100 patients had a partial knee rather than a total knee replacement, there would be 1 fewer death and 3 more re-operations in the first four years after surgery.”

This suggests that if the proportion of partial knee replacements carried out was increased from 8% to 20%, the NHS could potentially prevent 170 deaths at the cost of 400 additional revisions.

Revision, re-operation and death were uncommon outcomes of either procedure, the Oxford researchers stressed.

Professor Murray added, “Joint replacement, by making patients more mobile and fit, tends to save lives overall.”

The Oxford researchers, funded by Arthritis Research UK and the Royal College of Surgeons, used data from the National Joint Registry for England and Wales on the adverse outcomes of more than 100,000 patients who had undergone knee surgery.

Up to half of knees that require replacement, usually because of severe osteoarthritis, can be treated with either partial or total replacements.

Total knee replacement is one of the most common surgical procedures carried out, with over 76,000 performed annually in the UK. Only 5% of patients require revision surgery over a 10-year period.

Because of the higher revision rate of partial knee replacement surgery – which has traditionally been regarded as the most important factor in determining the choice of implant – its use in the treatment of end-stage osteoarthritis is controversial, with only about 7,000 being performed annually in the UK.

The researchers found that although the risk of life-threatening complications from knee replacement surgery is very small, people who undergo total knee replacement are four times more likely to die in the first month after surgery compared to those who have partial knee replacement and 15% more likely to die in the first eight years.

Patients undergoing total replacement are twice as likely to have a blood clot, heart attack or deep infection; three times as likely to have a stroke; and four times as likely to need blood transfusions – compared to those having partial replacement.

Patients who had a partial knee replacement are 40% more likely to have a re-operation, known as revision surgery, during the first eight years after the replacement.

Alex Liddle, an Arthritis Research UK clinical research fellow at Oxford University who ran the study, said, “Partial and total knee replacements are both successful treatments and a large proportion of patients with end-stage knee osteoarthritis are suitable for either. Both have advantages and disadvantages, and the choice of which procedure to offer will depend on the requirements and expectations of individual patient.”

Medical director of Arthritis Research UK, Professor Alan Silman, said, “This is a comprehensive study that provides both patients and surgeons with valuable information about the risk and benefits of two effective types of knee replacement operations. This new knowledge will enable them to make an informed decision about which type of surgery is best for particular individuals.

“Even in the elderly with other health problems, knee replacement is a very safe and effective procedure. These data remind us that there are still patients who, fortunately very rarely, can develop life threatening complications following surgery, and we still need to find surgical approaches that take away these risks whilst retaining a successful outcome for patients.”

Related Articles Read More >

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders
Withings Body Scan
Withings plans launch for Body Scan smart scale platform
BinaxNow COVID-19 Ag Card
Time recognizes Abbott offerings among this year’s 100 best inventions
Koya Medical’s Dayspring device
Koya Medical reports positive early results in Dayspring lymphedema trial

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech